查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1786450

DLIF 和 XLIF植入的全球市場

DLIF and XLIF Implants
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 278 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，DLIF 和 XLIF植入的全球市場規模將達到 18 億美元

全球DLIF和XLIF植入市場規模預計在2024年為15億美元，預計到2030年將達到18億美元，2024年至2030年的複合年成長率為2.6% 。退化性疾病應用是本報告分析的細分領域之一，預計其複合年成長率為3.1%，到分析期結束時市場規模將達到8.218億美元。椎間滑脫應用在分析期間內的複合年成長率預計為2.6%。

美國市場規模估計為 4.209 億美元，中國市場預計複合年成長率為 5.0%

預計到2024年，美國的DLIF和XLIF植入市場規模將達到4.209億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到3.476億美元，在2024-2030年的分析期間內，複合年成長率為5.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為0.9%和1.9%。在歐洲，預計德國市場的複合年成長率為1.4%。

全球 DLIF 和 XLIF植入市場 - 主要趨勢和促進因素摘要

微創脊椎手術的興起是否會推動 DLIF 和 XLIF植入的需求？

過去十年，脊椎外科領域經歷了重大的模式轉移，這得益於臨床和患者對微創手術 (MIS) 日益成長的偏好。其中，最具突破性的創新是直接側方椎間融合術 (DLIF) 和極側方椎間融合術 (XLIF)，這兩種手術允許外科醫生從側方入路而非傳統的前入路或後入路進入腰椎。這些手術旨在最大限度地減少肌肉和組織損傷、減少術中失血、縮短住院時間並加快患者康復。這些手術越來越受歡迎，主要是因為全球脊椎疾病發生率上升，尤其是在高齡化社會。隨著人們壽命延長和老年仍保持積極的生活方式，腰椎退化性椎間盤病、椎間滑脫和脊椎狹窄等疾病變得越來越常見。 DLIF 和 XLIF植入正日益受到青睞，因為它們在手術過程中對脊椎穩定和復位起到關鍵作用，能夠成功融合併最大程度地降低患者的患病率。醫院和門診手術中心也在投資設備和培訓以支持這些手術，這反映出各機構普遍致力於微創治療模式。外科醫生越來越傾向於使用這些方法，不僅因為它們具有臨床益處，還因為它們可以改善工作流程並縮短手術時間。此外，這些植入通常與最先進的術中神經監測和影像引導結合使用，以提高手術精確度並降低併發症風險。隨著醫療相關人員不斷採用和改進這些技術，對 DLIF 和 XLIF植入的需求預計將穩步成長，使它們成為未來脊椎融合手術不可或缺的一部分。

植入材料創新如何影響市場動態？

材料科學處於DLIF和XLIF植入市場創新的前沿，新成分和結構的進步顯著改善了植入的性能和患者的預後。傳統上，鈦因其強度和生物相容性而成為首選材料，但其滲透性使得術後成像困難。這促使人們轉向PEEK（聚醚醚酮）等材料，這種材料具有滲透性，並有助於術後骨癒合評估。此外，PEEK的彈性模數更接近天然骨，進而減少應力遮擋，促進更穩健的骨重塑。近年來，多孔鈦以及PEEK與鈦的混合材料因其能夠平衡可見度、骨整合和結構完整性而廣受歡迎。另一項突破性進展是利用3D列印技術製造具有客製化多孔結構的植入，這些植入物可以模擬鬆質骨，促進自然骨形成。這些積層製造的植入還可以根據患者特定的解剖學要求進行客製化，從而改善貼合度並降低併發症風險。此外，許多公司正在採用奈米紋理和生物活性塗層等表面處理技術，以增強細胞黏附並促進骨整合。這些創新技術正在縮短癒合時間，並提高脊椎手術的長期成功率。隨著植入設計的不斷發展，人們的注意力轉向多功能植入，這些植入物不僅具有機械穩定性，還具有生物學優勢。臨床研究開始證明這些先進材料具有卓越的療效，影響醫院和外科中心的採購決策。這項技術飛躍也得益於材料科學家、生物醫學工程師和骨科醫生之間的合作，旨在突破植入在現代脊椎護理中所能達到的極限。

醫療保健基礎設施和報銷政策的變化會改變市場准入嗎？

全球醫療服務格局正在發生重大變化，這些變化對 DLIF 和 XLIF植入的採用產生了重大影響。在美國、德國和日本等已開發國家，完善的醫療基礎設施和全面的保險覆蓋使這些植入能夠迅速融入常規外科手術中。在美國，醫療保險和私人保險公司提供優惠的報銷政策，鼓勵醫院投資 DLIF 和 XLIF 手術所需的專業培訓和設備。這種財政支持甚至使中型醫療機構也能夠採用這些先進的手術。相反，在亞洲、拉丁美洲和中東的一些新興市場，醫療保健系統處於不同的發展階段，促進或阻礙了這些技術的採用。然而，這些地區正看到醫療服務現代化和擴大的明顯趨勢。政府正在大力投資醫療基礎設施，私立醫院連鎖店正在激增，為日益壯大的中產階級提供優質的脊椎手術。由國際脊椎學會和全球醫療技術公司主導的培訓計畫正在幫助提升當地外科醫生在側入路融合技術方面的技能，從而推動市場擴張。同時，報銷模式也在不斷發展，越來越多的國家轉向以價值為基礎的醫療，獎勵 DLIF 和 XLIF 所特有的臨床效果和成本效益。此外，門診脊椎手術的興起，尤其是在美國和西歐，正在加速可用於更短、侵入性更小手術的植入的需求。對捆綁式支付和分期報銷的日益關注也鼓勵醫院選擇可最大限度減少併發症和再入院率的植入解決方案。這些制度變化正在重塑 DLIF 和 XLIF植入的獲取管道，使其更加普及，並擴大其在全球脊椎外科生態系統中的作用。

真正推動 DLIF 和 XLIF植入市場成長的因素是什麼？

DLIF 和 XLIF植入市場的成長受到多種因素的驅動，這些因素與技術創新、人口變化、外科手術的不斷發展以及最終用戶的期望密切相關。其中一個最重要的促進因素是退化性脊椎疾病和創傷性損傷的日益增多，這推動了對有效可靠的脊椎融合手術的需求。 DLIF 和 XLIF 手術以其微創特性而聞名，正迅速成為這些環境中的首選手術，從而推動了對其中所用植入的需求。手術導引、機器人輔助和術中影像的技術進步也是關鍵因素，因為這些工具可以實現高度精確的植入放置，改善臨床結果並增強外科醫生的信心。同樣重要的是手術偏好的轉變。骨科醫生和神經外科醫生越來越青睞側入路，這可以避免嚴重的肌肉損傷並縮短住院時間。患者越來越要求手術能夠提供更快的恢復、更少的疼痛和最小的疤痕，而 DLIF 和 XLIF 手術與合適的植入相結合，可以實現所有這些效果。門診手術中心 (ASC) 和當天出院選項的趨勢也推動了對支持更短、更有效率手術的植入的需求。此外，新興企業和成熟的醫療技術公司進入這一細分市場，正在加強研發力度，從而產生針對特定病患小組、脊椎病理和外科醫生偏好的更多樣化和先進的產品。市場參與企業也專注於與醫院和研究機構建立策略合作夥伴關係，以建立整合植入、器械、導航工具、培訓模組等的綜合程序生態系統。這些協同效應正在簡化手術流程並增加醫療保健提供者的價值。最後，對數據主導結果和長期成本效益的日益重視，正在推動醫療機構青睞再手術率更低、患者滿意度更高的植入系統，鞏固了 DLIF 和 XLIF植入在全球脊椎移植市場的地位。

部分

用途（退化性疾病用途、椎間滑脫用途、脊椎用途、其他用途）；最終用途（醫院最終用途、門診病人設施最終用途）

受訪公司範例

  • Alphatec Holdings, Inc.（ATEC Spine）
  • Aurora Spine Corporation
  • B. Braun Melsungen AG
  • Captiva Spine, Inc.
  • Centinel Spine, LLC
  • CoreLink, LLC
  • Curiteva
  • DePuy Synthes（Johnson & Johnson）
  • Exactech, Inc.
  • Globus Medical, Inc.
  • K2M Group Holdings, Inc.
  • Life Spine, Inc.
  • LDR Holding Corporation
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Osseus Fusion Systems
  • RTI Surgical Holdings, Inc.
  • SeaSpine Holdings Corporation
  • Spinal Elements, Inc.

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業產業SLM 的典型規範，而是建立了一個從世界各地專家收集的內容庫，包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP30553

Global DLIF and XLIF Implants Market to Reach US$1.8 Billion by 2030

The global market for DLIF and XLIF Implants estimated at US$1.5 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 2.6% over the analysis period 2024-2030. Degenerative Disc Diseases Application, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$821.8 Million by the end of the analysis period. Growth in the Spondylolisthesis Application segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$420.9 Million While China is Forecast to Grow at 5.0% CAGR

The DLIF and XLIF Implants market in the U.S. is estimated at US$420.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$347.6 Million by the year 2030 trailing a CAGR of 5.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Global DLIF and XLIF Implants Market - Key Trends & Drivers Summarized

Is the Rise of Minimally Invasive Spine Surgeries Fueling the Demand for DLIF and XLIF Implants?

Over the past decade, the field of spine surgery has witnessed a significant paradigm shift, with growing clinical and patient preference for minimally invasive surgical (MIS) techniques. Among the most transformative innovations are Direct Lateral Interbody Fusion (DLIF) and Extreme Lateral Interbody Fusion (XLIF), which allow surgeons to access the lumbar spine through a lateral approach rather than the traditional anterior or posterior route. These procedures are designed to minimize damage to muscles and tissues, reduce intraoperative blood loss, shorten hospital stays, and enable faster patient recovery. The increasing popularity of these techniques is largely driven by the global rise in spinal disorders, especially among the aging population. Conditions such as lumbar degenerative disc disease, spondylolisthesis, and spinal stenosis are becoming more prevalent as people live longer and maintain active lifestyles well into old age. DLIF and XLIF implants, which play a central role in stabilizing and realigning the spine during these procedures, are gaining momentum due to their ability to facilitate successful fusions with minimal patient morbidity. Hospitals and ambulatory surgical centers are also investing in equipment and training that support these techniques, reflecting a broader institutional commitment to less invasive care models. Surgeons are increasingly drawn to these approaches not only for their clinical benefits but also for improved workflow and reduced surgical times. Moreover, these implants are often used in combination with cutting-edge intraoperative neuromonitoring and imaging guidance, enhancing surgical accuracy and reducing the risk of complications. As medical professionals continue to adopt and refine these techniques, the demand for DLIF and XLIF implants is expected to grow steadily, making them integral to the future of spinal fusion surgeries.

How Are Innovations in Implant Materials Shaping Market Dynamics?

Material science is at the forefront of innovation in the DLIF and XLIF implants market, with new compositions and structural advancements significantly enhancing implant performance and patient outcomes. Traditionally, titanium was the material of choice due to its strength and biocompatibility, but its radiopaque nature made post-surgical imaging more difficult. This has led to a shift toward materials such as PEEK (polyether ether ketone), which offers radiolucency, allowing for easier post-operative assessments of bone fusion. Furthermore, PEEK's elastic modulus closely matches that of natural bone, reducing stress shielding and promoting healthier bone remodeling. In recent years, porous titanium and hybrid materials combining PEEK and titanium have gained popularity due to their ability to balance visibility, osteointegration, and structural integrity. Another groundbreaking development is the use of 3D printing technology to manufacture implants with customized porous architecture that mimics cancellous bone, which encourages natural bone in-growth. These additively manufactured implants can also be tailored to patient-specific anatomical requirements, improving fit and reducing the risk of complications. Additionally, many companies are incorporating surface treatments such as nano-texturing and bioactive coatings that enhance cell adhesion and accelerate osseointegration. These innovations reduce fusion time and increase the long-term success of spinal procedures. As implant designs continue to evolve, there is a growing focus on multi-functional implants that not only provide mechanical stability but also deliver biological benefits. Clinical studies have begun to document superior outcomes with these advanced materials, influencing purchasing decisions at hospitals and surgical centers. This technological leap is also being fueled by collaborations between material scientists, biomedical engineers, and orthopedic surgeons who are working together to push the boundaries of what implants can achieve in modern spine care.

Are Shifting Healthcare Infrastructures and Reimbursement Policies Altering Market Accessibility?

The global landscape of healthcare delivery is undergoing profound changes, and these shifts are significantly impacting the adoption of DLIF and XLIF implants. In developed nations such as the United States, Germany, and Japan, the presence of well-established healthcare infrastructure and comprehensive insurance coverage has enabled rapid integration of these implants into routine surgical practice. In the U.S., favorable reimbursement policies under Medicare and private insurers have encouraged hospitals to invest in the specialized training and equipment necessary for DLIF and XLIF procedures. This financial support has made it feasible for even mid-sized healthcare facilities to adopt these advanced techniques. Conversely, in emerging markets across Asia, Latin America, and parts of the Middle East, healthcare systems are at varying stages of development, which can either facilitate or hinder the adoption of these technologies. However, there is a clear trend toward modernization and expansion of healthcare services in these regions. Governments are investing heavily in medical infrastructure, and private hospital chains are proliferating, offering high-end spinal surgeries to a growing middle class. Training programs led by international spine societies and global medtech firms are helping to upskill local surgeons in lateral access fusion techniques, thereby driving market expansion. At the same time, reimbursement models are evolving, with more countries moving toward value-based care that rewards clinical efficacy and cost-efficiency-two hallmarks of DLIF and XLIF. Additionally, the rise of outpatient spinal surgeries, particularly in the U.S. and Western Europe, is accelerating demand for implants that are compatible with shorter, less invasive procedures. The increased focus on bundled payments and episode-based reimbursements is also encouraging hospitals to choose implant solutions that minimize complications and readmissions. These systemic changes are reshaping access to DLIF and XLIF implants, democratizing their availability and expanding their role in the global spine surgery ecosystem.

What’s Truly Powering the Market Expansion for DLIF and XLIF Implants?

The growth in the DLIF and XLIF implants market is driven by several factors that are deeply tied to innovation, demographic shifts, surgical evolution, and end-user expectations. One of the most significant drivers is the increasing prevalence of degenerative spinal conditions and trauma-induced injuries, which are fueling the need for effective and reliable spinal fusion procedures. DLIF and XLIF techniques, known for their minimally invasive nature, are becoming the procedures of choice in these scenarios, and the implants used in them are in growing demand. Technological progress in surgical navigation, robotic assistance, and intraoperative imaging is another critical factor; these tools allow for highly precise implant placement, thereby improving clinical outcomes and surgeon confidence. Equally important is the shift in surgical preferences-orthopedic surgeons and neurosurgeons are increasingly favoring lateral approaches due to their ability to avoid major muscle disruption and reduce hospital stays. On the patient side, there is a rising demand for surgeries that allow quicker recovery, less pain, and minimal scarring, all of which DLIF and XLIF procedures promise when paired with the right implants. The expanding trend of ambulatory surgical centers (ASCs) and same-day discharge options is also fueling demand for implants that support short-duration, high-efficiency procedures. Furthermore, the entry of startups and established medtech companies into this niche is intensifying R&D efforts, leading to more diverse and advanced product offerings tailored for specific patient groups, spinal pathologies, and surgeon preferences. Market players are also focusing on strategic collaborations with hospitals and research institutions to create comprehensive procedural ecosystems that integrate implants, instruments, navigation tools, and training modules. These synergies are streamlining the surgical process and creating value for healthcare providers. Lastly, the growing emphasis on data-driven outcomes and long-term cost-effectiveness is prompting institutions to favor implant systems that demonstrate lower revision rates and better patient satisfaction, cementing the position of DLIF and XLIF implants in the global spinal implants market.

SCOPE OF STUDY:

The report analyzes the DLIF and XLIF Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application, Other Applications); End-Use (Hospitals End-Use, Outpatient Facilities End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Alphatec Holdings, Inc. (ATEC Spine)
  • Aurora Spine Corporation
  • B. Braun Melsungen AG
  • Captiva Spine, Inc.
  • Centinel Spine, LLC
  • CoreLink, LLC
  • Curiteva
  • DePuy Synthes (Johnson & Johnson)
  • Exactech, Inc.
  • Globus Medical, Inc.
  • K2M Group Holdings, Inc.
  • Life Spine, Inc.
  • LDR Holding Corporation
  • Medtronic plc
  • NuVasive, Inc.
  • Orthofix Medical Inc.
  • Osseus Fusion Systems
  • RTI Surgical Holdings, Inc.
  • SeaSpine Holdings Corporation
  • Spinal Elements, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • DLIF and XLIF Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Minimally Invasive Spine Surgeries Throws the Spotlight on DLIF and XLIF Implant Demand
    • Rising Geriatric Population Propels Growth of Lateral Interbody Fusion Procedures
    • Increasing Adoption of Outpatient and Same-Day Spine Surgeries Strengthens Business Case for Minimally Invasive Implants
    • Advancements in 3D-Printed Implant Designs Expand Addressable Market Opportunity for Patient-Specific Solutions
    • Integration with Robotic and Navigation Systems Drives Adoption in High-Precision Surgical Environments
    • Emergence of Biocompatible and Osteoinductive Materials Accelerates Demand for Next-Gen Implant Platforms
    • Shift Toward Value-Based Healthcare Models Spurs Demand for Clinically Effective and Cost-Efficient Implant Solutions
    • Rising Prevalence of Degenerative Disc Disorders Generates Sustained Need for Fusion-Based Therapeutic Interventions
    • Increasing Preference for Lateral Access Approaches Over Traditional Methods Drives Market Realignment
    • Expanding Surgeon Training and Educational Initiatives Sustain Growth in Procedural Volumes
    • Growing Use of AI and Machine Learning in Surgical Planning Tools Enhances Appeal of Implant-Supported Procedures
    • Demand for Shorter Hospital Stays and Quicker Recovery Times Spurs Shift Toward Minimally Invasive Implant Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World DLIF and XLIF Implants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for DLIF and XLIF Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Degenerative Disc Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Degenerative Disc Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Degenerative Disc Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Spondylolisthesis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Spondylolisthesis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Spondylolisthesis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Scoliosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Scoliosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Scoliosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Outpatient Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Outpatient Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Outpatient Facilities End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for DLIF and XLIF Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for DLIF and XLIF Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for DLIF and XLIF Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for DLIF and XLIF Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for DLIF and XLIF Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • DLIF and XLIF Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for DLIF and XLIF Implants by Application - Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for DLIF and XLIF Implants by Application - Percentage Breakdown of Value Sales for Degenerative Disc Diseases Application, Spondylolisthesis Application, Scoliosis Application and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for DLIF and XLIF Implants by End-Use - Hospitals End-Use and Outpatient Facilities End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for DLIF and XLIF Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Outpatient Facilities End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION